Versant Vantage I, L.P., 10% Owner at LAVA Therapeutics NV (LVTX), sold 5,273,936 shares at $1.40 ($7.4M) on 2025-09-19, disclosed to the SEC on 2025-09-23.
Open-market sale of $7.4M LVTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 532,870 | $746K | 10.1% |
| 2 | $1.40 | 2,370,533 | $3.3M | 44.9% |
| 3 | $1.40 | 2,370,533 | $3.3M | 44.9% |
| Total | $1.40 avg | 5,273,936 | $7.4M | 100% |
| Filing → |
| BDTX | SELL | 2020-11-12 | $2.6M | — | Filing → |
| BDTX | SELL | 2020-11-10 | $586K | — | Filing → |
| RPTX | BUY | 2020-06-25 | $5.0M | — | Filing → |